Supriya Lifescience Share Price
906.30+5.65 (+0.63%)
+24.80% past 1 Year
Corporate filings & documents
Announcements
Intimation of Investor/ Analyst Call is enclosed herewith.Kindly take the same on record.
1 week agoIntimation of Investor/ Analyst Call is enclosed herewith.Kindly take the same on record.
1 week agoEnclosed herewith is the copy of Letter dispatched to shareholders whose email ids are not registered.Kindly take the same on record.
2 weeks agoEnclosed herewith is the copy of Letter dispatched to shareholders whose email ids are not registered.Kindly take the same on record.
2 weeks agoEnclosed herewith disclosure under Regulation 30.
2 weeks agoEnclosed herewith disclosure under Regulation 30.
2 weeks agoCopy of Newspaper Public for dispatch of AGM Notice and Annual Report.
2 weeks agoCopy of Newspaper Public for dispatch of AGM Notice and Annual Report.
2 weeks agoBusiness Responsibility and Sustainability Report for FY 2025-26
2 weeks agoBusiness Responsibility and Sustainability Report for FY 2025-26
2 weeks agoNotice of 18th AGM of the Company.
2 weeks agoNotice of 18th AGM of the Company.
2 weeks agoAnnual Report
2 weeks agoAnnual Report
2 weeks agoCopy of Newspaper Publication is enclosed.
3 weeks agoCopy of Newspaper Publication is enclosed.
3 weeks agoEnclosed herewith is the intimation of record date for determining list of members eligible to receive dividend for FY 2025-26.
3 weeks agoEnclosed herewith is the intimation of record date for determining list of members eligible to receive dividend for FY 2025-26.
3 weeks agoScrutinizers Report and Voting Results for Postal ballot conducted by the Company are enclosed herewith.
4 weeks agoScrutinizers Report and Voting Results for Postal ballot conducted by the Company are enclosed herewith.
4 weeks agoVoting Results and Scrutinizers Report for the Postal ballot conducted by the Company are enclosed herewith.
4 weeks agoVoting Results and Scrutinizers Report for the Postal ballot conducted by the Company are enclosed herewith.
4 weeks agoEarnings Call Transcript of the Earning Call for Unaudited Financial Results for quarter ended June 30 2026 is enclosed.
1 month agoEarnings Call Transcript of the Earning Call for Unaudited Financial Results for quarter ended June 30 2026 is enclosed.
1 month agoAudio Link for outcome of Results Earnings Call for United Financial Results for quarter ended June 30 2026 is enclosed.
1 month agoAudio Link for outcome of Results Earnings Call for United Financial Results for quarter ended June 30 2026 is enclosed.
1 month agoEnclosed herewith Copy of Newspaper Publication of Results for quarter ended June 30 2026.
1 month agoEnclosed herewith Copy of Newspaper Publication of Results for quarter ended June 30 2026.
1 month agoPress Release for Unaudited Financial Results for quarter ended June 30 2026 is enclosed herewith.
1 month agoInvestor Presentation for Results Earnings Call for Unaudited Financial Results for quarter ended June 30 2026 is enclosed herewith.
1 month agoInvestor Presentation for Results Earnings Call for Unaudited Financial Results for quarter ended June 30 2026 is enclosed herewith.
1 month agoUnaudited Financial Results for the quarter ended June 30 2026 is enclosed.
1 month agoUnaudited Financial Results for the quarter ended June 30 2026 is enclosed.
1 month agoPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its Meeting held on Thursday August 13 2026 inter-alia considered and approved Unaudited Financial Results for the Quarter ended June 30 2026. A copy of the same is enclosed along with the Limited Review Report of the Statutory Auditors thereon in terms of SEBI (LODR) Regulations 2015. The Meeting of the Board of Directors of the Company commenced at 03:30 p.m. and concluded at 06.00 p.m.Kindly take the above information on your records.
1 month agoPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company at its Meeting held on Thursday August 13 2026 inter-alia considered and approved Unaudited Financial Results for the Quarter ended June 30 2026. A copy of the same is enclosed along with the Limited Review Report of the Statutory Auditors thereon in terms of SEBI (LODR) Regulations 2015. The Meeting of the Board of Directors of the Company commenced at 03:30 p.m. and concluded at 06.00 p.m.Kindly take the above information on your records.
1 month agoIntimation of the Earnings call for Unaudited Financial Results of the Company for the quarter ended June 30 2026 is enclosed herewith.
1 month agoIntimation of the Earnings call for Unaudited Financial Results of the Company for the quarter ended June 30 2026 is enclosed herewith.
1 month agoSupriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this to inform you that a meeting of the Board of Directors of the Company will be held on Thursday August 13 2026 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30 2026.This is to further inform you that in accordance with the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company by Designated Persons and their immediate relatives is closed from July 1 2026 till 48 hours after declaration of Unaudited Financial Results on August 13 2026.
1 month agoSupriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve In terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this to inform you that a meeting of the Board of Directors of the Company will be held on Thursday August 13 2026 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30 2026.This is to further inform you that in accordance with the Companys Code of Conduct for Prevention of Insider Trading the Trading Window for dealing in the securities of the Company by Designated Persons and their immediate relatives is closed from July 1 2026 till 48 hours after declaration of Unaudited Financial Results on August 13 2026.
1 month agoPlease find attached copy of Newspaper Publication of Postal Ballot Notice.
1 month agoPlease find attached copy of Newspaper Publication of Postal Ballot Notice.
1 month agoPlease Find Attached Postal Ballot Notice of Supriya Lifescience Limited.
2 months agoPlease Find Attached Postal Ballot Notice of Supriya Lifescience Limited.
2 months agoEnclosed herewith is the Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 received from RTA.
2 months agoEnclosed herewith is the Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 received from RTA.
2 months agoEnclosed herewith is the intimation for submission under Regulation 30 of SEBI (LODR) Regulations 2015.
2 months agoEmail Communication to Shareholders regarding Dividend Taxation Provisions.
2 months agoEmail Communication to Shareholders regarding Dividend Taxation Provisions.
2 months agoEnclosed herewith is the intimation for trading window closure for declaration of Unaudited Financial Results for quarter ending on June 30 2026.
3 months agoEnclosed herewith is the intimation for trading window closure for declaration of Unaudited Financial Results for quarter ending on June 30 2026.
3 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Oct 2024
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
ConcallPresentation
May 2022
ConcallPresentation
Jan 2022